Literature DB >> 8106903

Pharmacokinetics of ciclopirox olamine after vaginal application to rabbits and patients.

G Coppi1, S Silingardi, R Girardello, D De Aloysio, S Manzardo.   

Abstract

The authors reported the plasma levels and pharmacokinetic parameters of ciclopirox olamine in rabbits after i.v. and intravaginal administrations and in female patients after vaginal administration. Plasma levels of total and free ciclopirox were determined by a HPLC method. In rabbit ciclopirox showed a half-life of 2.22 h and an intravaginal bioavailability of about 2%. In female patients ciclopirox showed low intravaginal absorption; this value might explain the good local and systemic tolerability and also the penetration of drug in deep tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8106903     DOI: 10.1080/1120009x.1993.11755468

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  5 in total

1.  Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.

Authors:  Claire S Danby; Dina Boikov; Rina Rautemaa-Richardson; Jack D Sobel
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

Review 2.  Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.

Authors:  Alessandro Subissi; Daniela Monti; Giuseppe Togni; Federico Mailland
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

3.  Breast intraductal nanoformulations for treating ductal carcinoma in situ II: Dose de-escalation using a slow releasing/slow bioconverting prodrug strategy.

Authors:  Firas Al-Zubaydi; Dayuan Gao; Dipti Kakkar; Shike Li; Jennifer Holloway; Zoltan Szekely; Nancy Chan; Shicha Kumar; Hatem E Sabaawy; Susan Love; Patrick J Sinko
Journal:  Drug Deliv Transl Res       Date:  2021-02-15       Impact factor: 4.617

4.  Sugar and iron: Toward understanding the antibacterial effect of ciclopirox in Escherichia coli.

Authors:  Zachary C Conley; Kimberly M Carlson-Banning; Ashley G Carter; Alejandro de la Cova; Yongcheng Song; Lynn Zechiedrich
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

5.  Repurposing of Ciclopirox to Overcome the Limitations of Zidovudine (Azidothymidine) against Multidrug-Resistant Gram-Negative Bacteria.

Authors:  Hyejin Cho; Kwang-Sun Kim
Journal:  Pharmaceutics       Date:  2022-03-01       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.